IMPORTANT NOTICE: Between May 20, 2018 and June 8, 2018 Takeda Educational Grants Web site will not be available for grant submissions. We are transitioning to a new grant system with an anticipated launch date of June 8, 2018. After that date please visit to register and submit new grant requests.


If you have active grants in our current system, please note:


  1. Grants requiring reconciliation: please complete in current system no later than May 25, 2018.
  2. Recently submitted grants under review: we are following our typical review cycle of 60-90 days, however we will make every attempt to communicate decisions by May 31, 2018.
  3. Any active approved grants: these will be transitioned to the new system.


If you have any questions, please contact the Learning and Evidence Integration team at 1-800-390-1204 or


Thank you for your patience during this process of transition!


US Medical Affairs Learning & Evidence Integration Team





Welcome to Takeda Pharmaceuticals U.S.A., Inc. Educational Grant Website.

This site is restricted to the submission of U.S. medical educational grant requests only.

Independent Medical Education


Takeda and its Alliance Partners are committed to supporting high-quality independent medical education.  Support is provided for activities designed to enhance the knowledge and skills of health care professionals and patients. Acceptable requests will address identified unmet educational needs and foster increased understanding of scientific, clinical, and health care issues that contribute to the enhancement of patient care.


In general, Takeda is currently seeking to support education delivered in formats that will engage the greatest number of learners and include evaluation plans designed to measure changes in knowledge, competence or performance of health care professionals. 


Current Educational Focus



Currently accepting and reviewing applications in the following areas of interest:


Inflammatory Bowel Disease  

Major Depressive Disorder   


Please check back periodically for updates to current areas of educational focus and call for grant applications (CGAs).


In the therapeutic area of Oncology, please submit requests to Millennium Pharmaceuticals, Inc., The Takeda Oncology Company (



Please allow a minimum of 60 days for full review of a proposal.  Takeda cannot approve requests after the activity has begun. To help us process your grant request within your required time frame, please submit your request as early as possible. Grant requests are reviewed for scientific and educational merit, audience scope, compliance with legal, ethical and professional obligations, as well as fiscal responsibility.  Takeda reserves the right to publicly disclose the grant recipient organization name, project title, project description, payee state, and dollar amounts awarded.


If you have questions please reference the FAQ document link below or contact a Grant Administrator at 1-800-390-1204 or 








  Forgot your Username?
Forgot your Password?
FAQ | Help | Terms & Conditions | Privacy Policy | Contact